CergenX
CergenX is a MedTech company focused on neonatal neurotechnology, developing AI-powered medical devices to assess newborn brain health. Their flagship product, CergenX Wave, is an FDA breakthrough-designated device that uses advanced AI and 2-channel EEG to provide rapid, objective brain function assessments in just 15 minutes. This device addresses the critical gap in neonatal neurological care by enabling all clinicians to perform expert-level EEG assessments quickly and easily, improving early detection of brain injury risks in newborns. The company leverages decades of neonatal research and extensive EEG data from the INFANT Research Centre, combining academic expertise with commercial innovation. CergenX operates on a SaaS and medical device business model, with a strong team of founders and experts in AI, neurophysiology, and technology. They have secured significant funding and ISO 13485 certification, positioning themselves as a pioneering force in neonatal brain health assessment with plans for steady growth and international expansion.
CergenX
CergenX is a MedTech company focused on neonatal neurotechnology, developing AI-powered medical devices to assess newborn brain health. Their flagship product, CergenX Wave, is an FDA breakthrough-designated device that uses advanced AI and 2-channel EEG to provide rapid, objective brain function assessments in just 15 minutes. This device addresses the critical gap in neonatal neurological care by enabling all clinicians to perform expert-level EEG assessments quickly and easily, improving early detection of brain injury risks in newborns. The company leverages decades of neonatal research and extensive EEG data from the INFANT Research Centre, combining academic expertise with commercial innovation. CergenX operates on a SaaS and medical device business model, with a strong team of founders and experts in AI, neurophysiology, and technology. They have secured significant funding and ISO 13485 certification, positioning themselves as a pioneering force in neonatal brain health assessment with plans for steady growth and international expansion.
TL;DR
Sector: MedTech — neonatal neurotechnology
Flagship product: CergenX Wave — AI-powered 2-channel neonatal EEG device
Key regulatory status: FDA Breakthrough Device designation
Founded / origin: 2021; spun out of University College Cork / INFANT Research Centre
Recent funding: Seed rounds in 2022 and Jun 2023; total disclosed seed funding ~€2.0M
~20 employees (company disclosure)